Correlation Between BKV and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BKV and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BKV and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BKV Corporation and Bristol Myers Squibb, you can compare the effects of market volatilities on BKV and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BKV with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of BKV and Bristol Myers.

Diversification Opportunities for BKV and Bristol Myers

0.53
  Correlation Coefficient

Very weak diversification

The 3 months correlation between BKV and Bristol is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding BKV Corp. and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and BKV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BKV Corporation are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of BKV i.e., BKV and Bristol Myers go up and down completely randomly.

Pair Corralation between BKV and Bristol Myers

Considering the 90-day investment horizon BKV Corporation is expected to generate 1.45 times more return on investment than Bristol Myers. However, BKV is 1.45 times more volatile than Bristol Myers Squibb. It trades about 0.04 of its potential returns per unit of risk. Bristol Myers Squibb is currently generating about -0.08 per unit of risk. If you would invest  2,142  in BKV Corporation on September 24, 2024 and sell it today you would earn a total of  27.00  from holding BKV Corporation or generate 1.26% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

BKV Corp.  vs.  Bristol Myers Squibb

 Performance 
       Timeline  
BKV Corporation 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in BKV Corporation are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak forward-looking signals, BKV showed solid returns over the last few months and may actually be approaching a breakup point.
Bristol Myers Squibb 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.

BKV and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BKV and Bristol Myers

The main advantage of trading using opposite BKV and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BKV position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind BKV Corporation and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
CEOs Directory
Screen CEOs from public companies around the world
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets